Hedgehog signaling is primarily transduced by two transcription factors: Gli2, which mainly acts as a full-length activator, and Gli3, which tends to be proteolytically processed from a full-length form (Gli3 FL ) to an N-terminal repressor (Gli3 REP ). Recent studies using a Sufu knockout mouse have indicated that Sufu is involved in regulating Gli2 and Gli3 activator and repressor activity at multiple steps of the signaling cascade; however, the mechanism of specific Gli2 and Gli3 regulation remains to be elucidated. In this study, we established an allelic series of ENU-induced mouse strains. residue of Sufu is specifically required for regulation of Gli3 but not Gli2. This implies a novel Sufu-mediated mechanism in which Gli2 activator and Gli3 repressor are differentially regulated.
Introduction
Hedgehog (Hh) signaling is a key regulatory cascade that is involved in many developmental processes and diseases [1, 2] . The Hh gradient is transduced through the activities of three Gli transcription factors: Gli1, Gli2, and Gli3, and directs pattern formation of tissues, including the embryonic neural tube and limb [3, 4] . Genetic studies have shown that while Gli1 is upregulated in a wide variety of tumors [5] , Gli1 KO mice show no morphological defects during development and are viable [6] [7] [8] . In contrast, mice lacking either Gli2 (Gli2 KO) or Gli3 (Gli3 Xt ) are embryonic lethal and exhibit distinct developmental defects; Gli2 KO mice are compromised in ventral neural tube specification [7, 9] , and Gli3 Xt mice develop exencephaly and polydactyly with a subtle patterning defect in intermediate region of the neural tube [6, 10, 11] . Both Gli2 and Gli3 have transcriptional activator and repressor domains in their C and N terminals, respectively [12, 13] . The presence of Hh is considered to convert the latent fulllength Gli2 and Gli3 (Gli FL ) to a labile activator (Gli ACT ) [14, 15] , which is subject to ubiquitinmediated degradation [16, 17] . In the absence of Hh signaling, Gli2 and Gli3 undergo sequential phosphorylation by multiple kinases and undergo limited proteolytic processing into a truncated N-terminal fragment, Gli REP [14, 18, 19] . Although Gli2 REP only minimally contributes to Hh signal transduction [5] , Gli3 REP is a potent negative regulator in vivo. The proteolytic processing of full-length Gli2 and Gli3 is mediated by Sufu [15, 20, 21] . In addition, Sufu antagonizes the complete degradation of Gli2 FL and Gli3 FL by antagonizing SPOP, which recruits ubiquitin ligase [16, 17, 20] . Notably, unlike Gli3 FL , the processed Gli3 REP is not subject to further regulation by Sufu [15, 20] . Previous studies of Sufu KO mice [22, 23] showed that Sufu −/− embryos exhibited elevated Hh signaling and died at around E9 of gestation owing to severe patterning defects. Examination of neural tube patterning revealed that Sufu −/− embryos exhibited abnormal activation of Gli ACT and a reduction in Gli REP indicating that loss of Sufu affected both Gli2 activator and Gli3 repressor activity [24] . However, how this differential effect was achieved remained unclear.
To uncouple Sufu-mediated Gli2 and Gli3 regulation at the genetic and biochemical level, we generated an allelic series of Sufu point mutations using the RIKEN ENU-based gene-driven mutagenesis system [25] . These Sufu mutations ranged from null to hypomorphic alleles. Analysis of one such hypomorphic allele, Sufu T396I , demonstrated a deficiency in Gli3 regulation, without qualitatively affecting the activities of Gli1 or Gli2. Further analysis of this missense mutation, presented in this report, revealed the novel function of the Thr 396 residue of Sufu to be an essential role in Gli3 processing and stability. Analysis of the Sufu T396I mutant mouse line together with the allelic series of the Sufu gene should shed light on the elucidation of the molecular mechanism of Gli transcription factor regulation. All of the Sufu and Smo mutant lines established in this study are available from RIKEN BioResource Center.
Results

Identification of novel mutations in Sufu
To identify functionally important residues in Sufu, we screened the ENU mutagenized mouse genome archive (details are described in the Materials and Methods in S1 File, and all identified mutations are listed in Table A in S1 File). Among the identified mutations, one point mutation, 1187C to T, leads to a substitution of threonine for isoleucine at Sufu residue 396 (T396I) (Fig. 1A) . A previous study on cultured cells by Merchant et al. [26] indicated that Sufu residues 388-398 were highly conserved between invertebrates and vertebrates and played an essential role in mediating the physical interaction of Sufu with the N-terminal region of Gli1.
On the basis of these findings, we anticipated that the T396I mutation would compromise Sufu-Gli1 interaction. However, analysis of Sufu T396I/T396I embryos revealed that the mutants developed phenotypes similar to those of mice lacking not Gli1 but Gli3 (Gli3 Xt/Xt ) [6, 10] . The Sufu T396I/T396I mice died at E14-18 with peripheral edema, hemorrhage, and severe morphological defects including exencephaly and polydactyly (Fig. 1B-D) . Craniofacial and limb defects in Sufu T396I/T396I were indicative of compromised Gli3 function [5] . In addition, Sufu T396I/T396I developed abnormal lungs that were small and thickened but had the correct number of lobes (Fig. 1E, F) , one of the characteristics similar to that observed in Gli3 Xt/Xt [27] .
These phenotypes were strikingly different from the early lethality and elevated Hh signaling previously reported for Sufu KO [22, 23] and recapitulated in our analysis of Sufu
R146X/R146X
null mutants established in the present study (Fig. 1A , G, H and S1 Fig.) . These findings suggested that the Thr 396 residue of Sufu is critical for the regulation of Gli3 repressor; we tested this hypothesis with further in vitro and in vivo studies as described below. embryos. Western blot analysis showed significant reduction of both Gli3 FL and Gli3 REP protein in Sufu T396I/T396I embryos at E10.5 ( Fig. 2A-C and S2A Fig.) . The expression level of Gli3 mRNA, assessed by RT-PCR, was unchanged in these mutants (S2B Fig.) , and wild-type embryos at E10.5 with anti-Gli3, anti-Sufu, and anti-actin antibodies. Each image presented in the Fig. is a representative of independent triplicated experiments. The full gel images are shown in S6A Fig. (B, C) Relative expression of Gli3 FL (B) and Gli3 REP (B and C). Western blotting was performed two times using lysates prepared from five wild-type and five Sufu T396I/T396I embryos at E10.5 (S2A Fig.) . Expression levels were quantified from the band intensity shown in S2A We found that expression of the Sufu protein was also reduced in Sufu T396I/T396I ( Fig. 2A and 5A). It must be noted that the expression of Sufu mRNA in Sufu T396I/T396I embryos was comparable to that in wild-type embryos (S3A Fig.) . The instability of Sufu T396I was also shown in vitro (S3B Fig.) . When the level of Sufu protein was examined after cycloheximide treatment, the Sufu T396I protein disappeared more rapidly than wild-type Sufu.
Sufu
Although Sufu residues 388-398 are required for Sufu-Gli1 interaction, substitution of Thr 396 to alanine or aspartate did not affect the physical binding of Sufu to Gli1 [26] . 
Gli3
REP activity was reduced in the Sufu T396I/T386I limb development
To evaluate the effect of Sufu T396I in vivo, we turned to the embryonic limb, given that Gli3 REP plays a critical role in the anteroposterior (AP) pattern of the digits [4] , and Sufu T396I/T396I mutants develop severe polydactyly with unpatterned digits, associated with compromised Gli3 function (Fig. 1C, D) . It is known that mutual antagonistic interactions between Gli3 and Hand2 are required to establish early AP patterning in the limb and correct expression of downstream genes including Alx4 and Pax9 in the anterior mesenchyme [28, 29] and Hand2 and Hoxd12 in the posterior mesenchyme [30] . Analysis of Sufu T396I/T396I limbs revealed decreased expression of Gli3 target genes Alx4 and Pax9 in the anterior of the limb (Fig. 3A , B, D, E) and ectopic expression of posterior genes Hoxd12 and Hand2 throughout the limb bud mesenchyme (Fig. 3G , H, J, K). These phenotypes were consistent with compromised Gli3 REP function [31] [32] [33] . To determine whether digit defects in Sufu T396I/T396I are due to impaired Gli3 REP activity, we forced expression of a constitutive Gli3 REP allele (Gli3 Δ699 ), which produces a truncated protein due to a premature termination codon [34] , in the Sufu T396I/T396I background. We showed that expression of Gli3 Δ699 was sufficient to rescue the expression of Alx4 and Pax9 (Fig. 3C, F ) and restore polarized expression of Hand2 and Hoxd12 (Fig. 3I, L) . These findings indicate that the patterning defects in the Sufu T396I/T396I limb may be attributed to compromised Gli3 REP activity.
Sufu T396I/T396I embryos lost Gli3 REP activity but retained Gli2 activity
To investigate whether the Sufu T396I mutation also affects Gli ACT as well as Gli REP , we analyzed development of the ventral neural tube, given that the generation of neural progenitor cells along its D-V axis is dependent on the Shh signaling gradient and Gli ACT activity [3] . In particular, activation of Gli2 is essential to generate floor plate (FoxA2 positive cells) and p3 progenitors (Nkx2.2 positive cells) in response to high Shh signaling (Fig. 4A , green and 4E) [35] .
Motor neuron progenitor cells (Olig2 positive cells) are generated dorsal to p3 progenitors in response to intermediate Shh signaling and a balance between Gli2 ACT and Gli3 REP (Fig. 4A , magenta) as has been reported before [11, 36] . Previous studies [37] [38] [39] mutation is a null allele, as also established in the present study (Table A in S1 File and S4 Fig.) . As in Smo −/− embryos [39] [40] [41] , the expression of FoxA2, Nkx2.2, and Olig2 was completely repressed in the ventral neural tube of Smo G457X/G457X (Fig. 4D, H 
Thr 396 is not required for regulation of Gli activators
To assess the effect of T396I on Gli2 stability and regulation, we compared the levels of fulllength Gli2 protein in wild-type and Sufu T396I/T396I embryos. We showed that expression of Gli2 was comparable in the point mutant and the wild-type embryos (Fig. 5A , lane 2 and S5A, B Fig.) . In contrast, Sufu −/− embryos were severely depleted in full-length Gli2 protein (Fig. 5A,   lane 1) . This is consistent with previous studies [16, 20] , in which Sufu is shown to be required to stabilize Gli2. Thus, although Thr 396 is critical for stabilization of full-length Gli3, it is dispensable for stabilization of Gli2. To further investigate how Thr 396 affects Gli1 and Gli2 function, we overexpressed Gli2 together with wild-type Sufu or Sufu T396I in cultured cells (Fig. 5C, lysate) . We detected no differences between wild-type Sufu and Sufu T396I with respect to stabilization of Gli2 protein, indicating that the activities of wild-type Sufu and Sufu T396I were qualitatively equivalent on Gli2 stabilization both in vitro and in vivo. In addition, consistent with a previous study [26] , we showed that Sufu T396I retained the ability to interact with Gli1 and Gli2 in immunoprecipitation experiments to similar or somewhat reduced extent as wild-type Sufu (Fig. 5B , C and Table B in S1 File). Finally, it is known that Sufu normally sequesters Gli1 and Gli2 to the cytoplasm [42] [43] [44] [45] [46] . Consequently, Sufu overexpression inhibits Gli1 and Gli2 trafficking into the nucleus and transcriptional activity. This activity can be detected by assessing the transcriptional activation of a reporter gene, 8xGliBS, controlled by Gli1 and Gli2 [13, 42] . To determine whether Sufu In our experimental settings, we observed approximately only 4-fold induction of luciferase reporter activity by Gli1 expression, as had been observed previously [46] . doi:10.1371/journal.pone.0119455.g005
Gli3 Regulation by Thrhad a similar repressive activity, we performed a reporter assay in 3T3 cells, a Hh-responsive cell line. We found that Sufu T396I was able to repress the transcriptional activation of the 8xGliBS reporter by both Gli1 (Fig. 5D ) and Gli2 (Fig. 5E ), similar to wild-type Sufu. In addition, a titration assay showed the Gli1 and Gli2 activities were proportional to the amount of Sufu irrespective of either wild-type or the T396I substitution (S8 Fig.) . Thus, the repressor activities of wild-type Sufu and Sufu T396I were qualitatively equivalent on Gli1 and Gli2 regulations. This finding strongly suggested that the Thr 396 residue of Sufu is not required for the stabilization or transcriptional activity of Gli1 and Gli2.
Discussion
In this work, we showed that Sufu T396I missense mutant mice uncouple molecular regulation of Gli3 from Gli1/2. This mutant was generated as part of an allelic series using the RIKEN ENU gene-driven mutagenesis system. The results presented here show that generation of point mutations in critical regulatory residues make it feasible to connect biochemical interactions between key molecules in the Hh signaling pathway with the genetics of the system.
Phenotype of Sufu T396I/T396I is attributed to a loss of Gli3 regulation
We conclude that the alteration of Sufu function due to T396I substitution rather than the reduction of the Sufu amount per se, is a major primary cause of morphological defects in 
Distinct regulation of Gli activator and Gli3 repressor by Sufu
Recent reports [15, 16, 20] [19, 47] . Thus, Sufu independently regulates two proteasome-related processes that control both the amounts and activities of Gli2 and Gli3. However, whether Sufu regulates Gli2 and Gli3 through a common action or different actions remains unknown. Our observations that Sufu T396I was able to control Gli2 but not Gli3 are strong evidence of distinct regulatory mechanisms of Gli activator and repressor. Namely, one is the Thr 396 -independent regulation of Gli2 and the other is the Thr 396 -dependent regulation of stability and proteolytic processing of Gli3.
Three-dimensional structure of Sufu and its interaction with Gli
Recent studies have solved the 3D structures of full-length human Sufu alone and in a complex with a Gli-derived peptide containing the N-terminal SYGHL Gli motif [48, 49] . They showed that Sufu consists of N-and C-terminal globular domains with a short linker and displays "open" and "closed" conformations. Activation of Hh signaling is associated with promotion of the open form of Sufu and dissociation of Gli, whereas inhibition of the signaling is associated with promotion of the closed form of Sufu and Gli binding. The Thr 396 residue of Sufu is located on strand β-13 that juxtaposes strand β-9, which mediates Gli-binding [48] . Thus, substitution of Thr 396 would not directly affect interaction between strand β-9 of Sufu and the SYGHL motif of Gli. In addition, a previous study in cultured cells indicated that substitution of Thr 396 to alanine (T396A) or aspartic acid (T396D) did not affect the physical interaction of Sufu with Gli1 [26] . In the present study, we have also found that Sufu T396I still retains the ability to physically interact with Gli1, Gli2, and Gli3 with similar or somewhat reduced extent to wild-type Sufu. Thus, structural insight and molecular biology support our hypothesis that substitution of Thr 396 does not affect the gross structure that constitutes the Gli binding site and mediates direct physical interaction with Gli. In contrast to these structural studies, previous deletion mapping approaches indicated that the N-and C-terminal fragments of Sufu were able to separately bind Gli1 and Gli2 (Fig. 1A ) [26, 46] . In particular, substitution of residues 388-398 of Sufu with an alanine homopolymer disrupted its physical interaction with an N-terminal fragment of Gli1. This observation implies an interaction(s) between Gli and the C-terminal region of Sufu, which includes Thr 396 , in addition to the above mentioned physical interaction between the SYGHL motif of Gli and strand β9 of Sufu. Given our findings, this possible interaction is likely to be associated with precise regulation specific to Gli3 but not Gli2.
Thr 396 is essential for regulation of Gli3 activity
A recent study has shown that Sufu recruits GSK3β and forms the trimolecular complex Gli3/ Sufu/GSK3β [21] . In the absence of Hh, GSK3β in the trimolecular complex efficiently phosphorylates Gli3 FL , leading to Gli3 ubiquitination and then proteolytic processing to generate Gli3 REP [18] . The GSK3β-binding region of Sufu is defined as the medial region between residues 304 and 315 (Fig. 1A ) [21] , which is part of the "intrinsically disordered region" (IDR) indicated by the 3D structure of full-length human Sufu [48, 49] . IDR is a flexible loop with no fixed structure and appears to shield the Gli-binding surface of Sufu in response to upstream signaling. Thus, substitution of Thr 396 may indirectly affect the flexibility of IDR, leading to failure of the trimolecular complex formation with GSK3β or regulation of the GSK3β activity. Embryonic lethal mutations in Drosophila enabled the elucidation of molecular pathways and key elements in early embryogenesis [50] . The allelic series of target genes in a specific gene network, such as Hh signaling as described in this study, should prime analogous molecular approaches for the elucidation of molecular mechanisms in mammalian development.
Materials and Methods
Mutation screening
ENU mouse mutagenesis and gene-driven screening were described in Materials and Methods in S1 File in details. The primers used for the mutation screening are listed in Table C in S1 File. All the identified ENU-induced mutations in the Sufu and Smo genes are summarized in Table D in S1 File.
Mice
All animal work was conducted according to the protocols and guidelines approved by the ethics committee of RIKEN Tsukuba Institute (Permit number: 14-012). The animals were sacrificed by cervical dislocation. Sufu T396I , Sufu R146X , and Smo G457X lines were revived from ENU Mutant Mouse Library (reviewed by Gondo) [25] by a conventional IVF technique after the mutation screening. Congenic lines of these three mutations were established by breeding more than 10 generations of backcrosses to C57BL/6J strain. Details of genotyping are described in Materials and Methods in S1 File with all the used primer information in Table C , E, and F in S1 File. The Gli3 Δ699 mouse line [34] and the Sufu −/− mouse line [51] were maintained on CD1 background. ENU mouse mutant lines are available from RIKEN BioResource Center.
Molecular biology and constructs
Sufu cDNA [42] and mouse Gli3 cDNA were N-terminally tagged with HA and 3xFlag, respectively. Point mutations of Sufu R146X , Sufu T396I , and Smo G457X were introduced with the QuickChangeII Site-Directed Mutagenesis Kit (Agilent Technologies). All constructs were verified by direct sequencing. Plasmids expressing Flag-Gli1and Flag-Gli2, were previously described [42] .
Cell culture and transfection
Cells were grown in DMEM supplemented with 10% fetal bovine serum, penicillin, and streptomycin. NIH3T3 and 293T cells were transfected with HilyMax transfection reagent (Dojindo Laboratories). MEFs were prepared from WT and Sufu T396I/T396I embryos at E13.5 according to standard techniques [23] with the above medium. Because the Sufu −/− cells and MEFs had a low transfection efficiency by lipofection, the cells were electroporated with a MEF2 Nucleofector kit (Lonza) using an A-23 program according to the manufacturer's instructions. The total amount of DNA for electroporation was adjusted to 10 μg by addition of the pUC vector as a control plasmid.
Luciferase reporter assay
Reporter assay was performed by transfecting 250 ng of reporter vector with firefly luciferase under the control of eight Gli binding sites [13] , 50 ng of pRLTK (Promega) as a Renilla control, and 100 ng of Gli1 or Gli2 and 100 ng of Sufu expression constructs, into NIH3T3 in a 24-well plate. After confluence was reached, the culture medium was replaced with a lowserum (0.5%) medium and cultured for an additional 24 h. Cells were harvested and luciferase activity was measured with a Dual Luciferase Reporter Assay System (Promega) on an ARVO MX 1420 Multilabel Counter System (Perkin Elmer). Each assay was calculated from triplicate wells, and at least three independent assays were performed. Data from a representative experiment are shown in the figures. The statistical analysis in Fig. 5 was conducted as follows. Firstly, the effects of the Sufu repressor activity on Gli1 and Gli2 were calculated by:
The repressor activity of the wild À type Sufu ¼ lane4 À lane3 ¼ RepðwildÞ ð 1Þ
The repressor activity of the T396I Sufu ¼ lane6 À lane3 ¼ RepðT396IÞ ð 2Þ Then, the difference of the repressor activities between wild-type and T396I Sufu, namely Rep (wild)-Rep(T396I), was subjected to two-tailed Student' t-test.
Coimmunoprecipitation
Twenty-four hours after transfection, 293T cells were lysed in a lysis buffer (0.1 mM Tris-HCl (pH 7.5), 0.3 M NaCl, 2% Nonidet P-40, 2 mM EDTA, and Complete Mini protease inhibitor cocktail (Roche) for 10 min on ice. Following centrifugation, cleared lysates were incubated with anti-HA magnetic beads (Medical & Biological Laboratories) or anti-FLAG M2 magnetic beads (Sigma) for 2 h at 4°C with constant nutation. Beads were washed three times with lysis buffer and mixed with SDS loading buffer. Supernatants were analyzed by western blotting.
Western blotting
Dissected embryos were lysed in lysis buffer for 10 min on ice. Following centrifugation, the protein concentration of cleared lysates was determined by Quick Start Bradford protein assay (BioRad). Equal amount of protein was resolved on 6% SDS-PAGE gels. The transferred membrane was immunoblotted with the SNAP i.d. system according to the manufacturer's instructions (Merck Ltd.). Chemiluminescence images were captured with a LAS 3000 imaging system (GE Healthcare) except for . The primary and secondary antibodies used were rabbit anti-Gli2 [16] , goat anti-Gli3 (AF3690, R&D Systems), rabbit anti-Sufu ( Fig. 5A and S5A Fig.) [52], rabbit anti-Sufu (except Fig. 5A and S5A Fig.) 
Immunohistochemistry and in situ hybridization
Immunohistochemistry was performed with 7 μm paraffin embedded sections as previously described [53] . The antibodies used were Pax7 (bio reactor, 1/500), Nkx6.1 (concentrate, 1/ 6000), Nkx2.2 (concentrate, 1/600), and FoxA2 (concentrate, 1/100) from Developmental Studies Hybridoma Bank, and Olig2 (AB9610, 1/6000) from Millipore. Images were acquired with an LSM510 Laser Scanning Microscope (Zeiss). Whole mount in situ hybridization was performed with digoxigenin-labeled riboprobes against Hand2, Alx4, Hoxd12, and Pax9 as described [7] .
Supporting Information 
